|
Prospective Study of Androgen Ablation,
High Dose Rate Temporary Conformal Brachytherapy and Conformal External Beam Radiotherapy
for Locally Advanced, Organ Confined, High Risk Prostate Cancer, 82nd Annual Meeting
of the American Radium Society, London, England, April 2000. Patterns
and Predictors of Acute Toxicity after HDR Brachytherapy and 3D-CRT for Localized
Prostate Cancer: Preliminary Results of Phase I-II Dose Escalation Study, 11th
International Prostate Cancer Update, Santa Fe, New Mexico, June 2001. High
Dose Intensity Modulated Radiotherapy (IMRT) for Localized Prostate Cancer in
a Community Practice: Preliminary Results on Acute Toxicity and Quality of Life,
12th International Prostate Cancer Update, Keystone, Colorado, February 2002.
Preliminary Analysis of the Accuracy of
the VariSeed Real-Time Dosimetric Optimization Program for Permanent Radioactive
Seed Implantation (PSI) of the Prostate: Real Time or Real Myth?, 12th International
Prostate Cancer Update, Keystone, Colorado, February 2002. Patterns
and Predictors of Acute Toxicity after HDR Brachytherapy and 3D-CRT for Localized
Prostate Cancer: Preliminary Results of Phase I-II Dose Escalation Study, American
Brachytherapy Society Proceedings, Vancouver, British Columbia, Canada, May 2002.
Preliminary Analysis and First Report of
the Accuracy and Predictive Value of the VariSeed Real-Time Dosimetric Optimization
Program (Version 6.7) for Permanent Radioactive Seed Implantation (PSI) of the
Prostate, 88th Scientific Assembly and Annual Meeting of the Radiology Society
of North America, Chicago, Illinois, December 2002. High
Dose Intensity Modulated Radiotherapy (IMRT) for Localized Prostate Cancer in
a Community Practice: Preliminary Results on Acute Toxicity and Quality of Life,
88th Scientific Assembly and Annual Meeting of the Radiology Society of North
America, Chicago, Illinois, December 2002. Comparison
of real-time US implantation of the prostate using a look-up nomogram versus US
assisted implantation using the VariSeed Optimization Program: improved target
coverage with reduced urethral and rectal dose, 24th Annual Meeting of the American
Brachytherapy Society, New York, New York, May 2003.
Posters
Preliminary Analysis and First Report of
the Accuracy and Predictive Value of the VariSeed Real-Time Dosimetric Optimization
Program (Version 6.7) for Permanent Radioactive Seed Implantation (PSI) of the
Prostate, 11th International Prostate Cancer Update, Santa Fe, New Mexico, June
2001. Acute and Late Morbidity, and Preliminary
Biochemical Control After Combined Androgen Blockade, High Dose Rate Brachytherapy
and 3D-Conformal Radiotherapy: Follow-up Results of a Prospective Phase I/II Dose
Escalation Trial, 21st Annual Estro Meeting, Prague, Czechoslovakia, September
2002. Feasibility and Safety of High Dose
Intensity Modulated Radiotherapy (IMRT) for Localized Prostate Cancer in a Community
Practice: Preliminary Results on Acute Toxicity, 21st Annual Estro Meeting, Prague,
Czechoslovakia, September 2002. Preliminary
Analysis and First Report of the Accuracy and Predictive Value of the VariSeed
Real-Time Dosimetric Optimization Program (Version 6.7) for Permanent Radioactive
Seed Implantation (PSI) of the Prostate, 21st Annual Estro Meeting, Prague, Czechoslovakia,
September 2002.
Papers
Patterns
and Predictors of Acute Toxicity after HDR Brachytherapy and 3D-CRT for Localized
Prostate Cancer: Preliminary Results of Phase I-II Dose Escalation Study, A. Raben,
MD, J.Geltzeiler, A.Grebler, MD, S.Litvin, MD, I.Keselman, MD, Journal of Brachytherapy
International, Vol. 17, #2, April – June 2002. Analysis
and First Report of the Accuracy and Predictive Value of the VariSeed Real-Time
Dosimetric Optimization Program (Version 6.7) for Permanent Radioactive Seed Implantation
(PSI) of the Prostate, A. Raben, MD, J. Geltzeiler, MD, A.Grebler, MD, S.Litvin,
MD, I.Keselman, MD, Radiotherapy & Oncology, Vol. 64, Supplement 1, September
2002. Comparison of real-time US implantation
of the prostate using a look-up nomogram versus US assisted implantation using
the VariSeed Optimization Program: improved target coverage with reduced urethral
and rectal dose, A. Raben, H. Chen, et al, Brachytherapy, Vol. 2, #1, May 2003. |
